Levofloxacin shows limited efficacy in preventing multidrug-resistant tuberculosis
1. In this randomized controlled trial, daily levofloxacin treatment in patients with multidrug-resistant (MDR) or rifampicin-resistant Mycobacterium tuberculosis did not ...